Cargando…

Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells

Oncolytic herpes simplex virus type 1 (HSV-1) strain RH2 induced immunogenic cell death (ICD) with the release and surface exposure of damage-associated molecular patterns (DAMPs) in squamous cell carcinoma (SCC) SCCVII cells. The supernatants of RH2-infected SCCVII cells also exhibited antitumor ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tada, Shinya, Hamada, Masakazu, Yura, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836060/ https://www.ncbi.nlm.nih.gov/pubmed/29360750 http://dx.doi.org/10.3390/cancers10020028

Ejemplares similares

Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound
por: Okunaga, Shusuke, et al.
Publicado: (2015)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
por: Takaoka, Hiroo, et al.
Publicado: (2011)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
por: Yura, Yoshiaki
Publicado: (2017)

Effect of ultrasound on herpes simplex virus infection in cell culture
por: Shintani, Motoko, et al.
Publicado: (2011)

The Proteome and Secretome of Cortical Brain Cells Infected With Herpes Simplex Virus
por: Hensel, Niko, et al.
Publicado: (2020)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
por: Hamada, Masakazu, et al.
Publicado: (2020)

Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
por: Ghose, Jayeeta, et al.
Publicado: (2021)

Treatment of breast cancer stem cells with oncolytic herpes simplex virus
por: Li, J, et al.
Publicado: (2012)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
por: Nguyen, Hong-My, et al.
Publicado: (2021)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
por: Hong, Bangxing, et al.
Publicado: (2022)

Herpes simplex virus-infected squamous cell carcinoma: a case report
por: Brown, Sarah H., et al.
Publicado: (2022)

Detection of herpes simplex virus in oral tongue squamous cell carcinoma
por: Koivikko, Tiina, et al.
Publicado: (2023)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
por: Suzuki, Takuma, et al.
Publicado: (2021)

Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
por: Wang, Jiani, et al.
Publicado: (2014)

Dynamic Proteomics of Herpes Simplex Virus Infection
por: Drayman, Nir, et al.
Publicado: (2017)

A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells
por: Leoni, Valerio, et al.
Publicado: (2017)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
por: Kardani, Kimia, et al.
Publicado: (2023)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
por: Gillory, Lauren A., et al.
Publicado: (2013)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
por: Menotti, Laura, et al.
Publicado: (2020)

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
por: Scanlan, Hayle, et al.
Publicado: (2022)

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
por: Hu, Mingming, et al.
Publicado: (2023)

Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma
por: Yura, Yoshiaki, et al.
Publicado: (2020)

Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells
por: Hamada, Masakazu, et al.
Publicado: (2017)

Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus
por: Reinhart, Bonnie, et al.
Publicado: (2012)

Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
por: Cody, James J., et al.
Publicado: (2014)

Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
por: Warner, Susanne G, et al.
Publicado: (2016)

Stability and anti-tumor effect of oncolytic herpes simplex virus type 2
por: Wang, Yang, et al.
Publicado: (2018)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
por: Boscheinen, Jan B., et al.
Publicado: (2019)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
por: Cockle, Julia V., et al.
Publicado: (2017)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
por: Woo, Yanghee, et al.
Publicado: (2019)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
por: Bernstock, Joshua D., et al.
Publicado: (2021)

Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma
por: Wang, Jia-Ni, et al.
Publicado: (2011)

Involvement of intracellular free Ca(2+ )in enhanced release of herpes simplex virus by hydrogen peroxide
por: Arimoto, Emiko, et al.
Publicado: (2006)

Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo
por: Fan, Jingjing, et al.
Publicado: (2021)

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
por: Islam, S. M. Bakhtiar Ul, et al.
Publicado: (2020)

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
por: Ning, Jianfang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rg53ig54bcaq7meincvddl0nnm